Acute lung injury (ALI) describes the injury to endothelial cells in the lungs and associated
vessels due to various factors. Furthermore, ALI accompanied by inflammation and …

The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive scarring interstitial lung disease
with an unknown cause. Some patients may experience acute exacerbations (AE), which …

The pathogenic hyper-inflammatory response has been revealed as the major cause of the
severity and death of the Corona Virus Disease 2019 (COVID-19). Xuanfei Baidu Decoction …

Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …

Abstract Acute Respiratory Distress Syndrome (ARDS), associated with Covid-19 infections,
is characterized by diffuse lung damage, inflammation and alveolar collapse that impairs …

The acute respiratory distress syndrome (ARDS) is a common complication of severe COVID-
19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome …

Acute lung injury is a fatal condition characterized by excessive inflammation responses.
Salidroside, the active constituent of Rhodiola rosea, possesses properties including anti …

Ethnopharmacological relevance Acute lung injury (ALI) is one of the fatal complications of
respiratory virus infections such as influenza virus and coronavirus, which has high clinical …

Rationale Alveolar epithelial cell death, inflammation, and oxidative stress are typical
features of acute lung injury (ALI). Aloperine (Alo), an alkaloid isolated from Sophora …